Acura Pharmaceuticals, Inc. (NASDAQ: ACUR)


Date: 
Tue, 04/05/2011

 April 5th, 2011 we released our published article, "TooNiceStocks Initiates Coverage on Acura Pharmaceuticals Inc. (NASDAQ: ACUR) Pending June 17th, 2011 FDA Decision with Elevated Interest". Our members were notified @ $3.70 and later ran to $4.99  rallying up to 34.86%  ACUR's lead product acurox was granted a priority review with the Prescription Drug User Fee Act and to manufacture and market without having to file a new drug application.  Read full report here.

 



Join our Free Newsletter!